BLLN
BillionToOne, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Neutral
+4/100
Last price
99.94
▼ 9.12 (8.36%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
—
Prev close
109.06
Day high
112.87
Day low
98.96
Volume
1.12M
Market cap
$4.72B
P/E (TTM)
158.63
52W range
61.96 – 150.44
Trailing performance
Returnvs SPY
1W
-15.43%
-17.4%
1M
+0.55%
-0.6%
3M
-17.13%
-21.7%
6M
+12.99%
-5.2%
YTD
+22.12%
+7.9%
1Y
—
-16.4%
3Y
—
-82.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on BLLN open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+8.51K
Net buying
Buy transactions
28
411.40K shares
Sell transactions
30
402.89K shares
Net transactions
+58
Buys less sells
Sell : buy shares
1.0 : 1
Mixed
Insider-held shares
13.38M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Sep 28, 26 | ATAY OGUZHAN PH.D. Chief Executive Officer |
SELL | 11.00K | $1.33M | |
| Sep 28, 26 | ATAY OGUZHAN PH.D. Chief Executive Officer |
CONVERSION | 8.33K | $23.33K | Direct |
| Sep 24, 26 | TEN BOSCH JOHN RODERICK PH.D. Officer |
SELL | 1.42K | $169.92K | Direct |
| Sep 24, 26 | TSAO DAVID PH.D. Chief Technology Officer |
SELL | 3.33K | $416.63K | Direct |
| Sep 24, 26 | TSAO DAVID PH.D. Chief Technology Officer |
CONVERSION | 3.33K | $9.33K | Direct |
| Sep 21, 26 | TEN BOSCH JOHN RODERICK PH.D. Officer |
SELL | 1.42K | $150.96K | Direct |
| Sep 17, 26 | LYNCH THOMAS P General Counsel |
SELL | 35.11K | $3.87M | Direct |
| Sep 17, 26 | LYNCH THOMAS P General Counsel |
CONVERSION | 35.11K | $477.90K | Direct |
| Sep 14, 26 | ATAY OGUZHAN PH.D. Chief Executive Officer |
SELL | 30.33K | $3.03M | |
| Sep 14, 26 | ATAY OGUZHAN PH.D. Chief Executive Officer |
CONVERSION | 25.00K | $70.00K | Direct |
| Sep 10, 26 | SAKAKIBARA SHAN RIKU Officer |
STOCK | 3.50K | $0 | Direct |
| Sep 9, 26 | ATAY OGUZHAN PH.D. Chief Executive Officer |
STOCK | 20.00K | $0 | Direct |
| Sep 9, 26 | TEN BOSCH JOHN RODERICK PH.D. Officer |
SELL | 1.42K | $138.12K | Direct |
| Sep 9, 26 | TSAO DAVID PH.D. Chief Technology Officer |
SELL | 20.00K | $1.98M | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
ATAY OGUZHAN PH.D. |
Chief Executive Officer | — | Sale |
BREMNER THOMAS S. |
Director | 11.35K | Stock Award(Grant) |
HUMMING BIRD VENTURES MANAGEMENT NV |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
ILERI FIRAT |
Director and Beneficial Owner of more than 10% of a Class of Security | 40.33K | Stock Award(Grant) |
KOLLURI KRISHNA KITTU |
Director and Beneficial Owner of more than 10% of a Class of Security | 11.35K | Stock Award(Grant) |
NEOTRIBE VENTURES I L.P. |
Beneficial Owner of more than 10% of a Class of Security | — | Conversion of Exercise of derivative security |
PAGANO ANTHONY |
Director | 7.91K | Stock Award(Grant) |
RAI AKSHAY |
Director | 14.03K | Stock Award(Grant) |
SAKAKIBARA SHAN RIKU |
Officer | 196.50K | Stock Gift |
TEN BOSCH JOHN RODERICK PH.D. |
Officer | 22.22K | Sale |
Fundamentals
Market cap$4.72B
Enterprise value$4.31B
Revenue (TTM)$397.41M
Gross profit$283.22M
EBITDA$50.24M
Net income$33.18M
EPS (TTM)$0.63
Free cash flow$12.03M
Total cash$548.63M
Total debt$143.92M
Book value / share$11.46
Shares outstanding42.64M
Float28.82M
Short % of float10.04%
Dividend yield0.00%
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E158.63
Forward P/E67.30
PEG ratio—
Price / sales—
Price / book8.72
EV / revenue10.85
EV / EBITDA85.81
Gross margin71.27%
Operating margin5.03%
Profit margin8.35%
Return on equity10.68%
Return on assets5.19%
Debt / equity26.81
Current ratio11.69
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Total revenue | $305.11M | — | — | — |
| Operating revenue | $305.11M | — | — | — |
| Cost of revenue | $96.65M | — | — | — |
| Gross profit | $208.46M | — | — | — |
| Research & development | $49.38M | — | — | — |
| Selling, general & admin | $143.05M | — | — | — |
| Total operating expense | $192.44M | — | — | — |
| Operating income | $16.02M | — | — | — |
| Net interest income | $7.66M | — | — | — |
| Pre-tax income | $7.76M | — | — | — |
| Tax provision | $305.00K | — | — | — |
| Net income | $7.45M | — | — | — |
| Net income to common | $2.92M | — | — | — |
| Basic EPS | 0.18 | -1.05 | -2.10 | +117.1% |
| Diluted EPS | 0.14 | -1.05 | -2.10 | +113.3% |
| EBIT | $7.85M | — | — | — |
| EBITDA | $19.76M | — | — | — |
| Basic shares | 15.88M | 39.43M | 39.43M | -59.7% |
| Diluted shares | 21.23M | 39.43M | 44.72M | -46.2% |
| Line item | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|
| Cash & equivalents | $495.98M | — | — | — |
| Cash & short-term investments | $495.98M | — | — | — |
| Accounts receivable | $41.62M | — | — | — |
| Inventory | $17.55M | — | — | — |
| Total current assets | $560.56M | — | — | — |
| Property, plant & equipment | $66.52M | $68.62M | — | -3.1% |
| Goodwill & intangibles | $587.00K | $227.00K | — | +158.6% |
| Total assets | $632.65M | — | — | — |
| Total current liabilities | $47.96M | — | — | — |
| Long-term debt | $57.23M | — | — | — |
| Total debt | $108.89M | — | — | — |
| Total liabilities | $152.55M | — | — | — |
| Retained earnings | -$274.75M | — | — | — |
| Shareholder equity | $480.11M | — | — | — |
| Working capital | $512.60M | — | — | — |
| Net tangible assets | $479.52M | -$251.88M | — | +290.4% |
| Shares issued | 45.80M | 44.72M | 44.72M | +2.4% |
| Line item | 2025 | YoY |
|---|---|---|
| Net income | $7.45M | |
| Depreciation & amortisation | $11.91M | |
| Stock-based compensation | $15.91M | |
| Change in working capital | -$22.05M | |
| Operating cash flow | $24.59M | |
| Capital expenditure | -$8.92M | |
| Investing cash flow | -$8.92M | |
| Share buybacks | $0 | |
| Financing cash flow | $288.82M | |
| Free cash flow | $15.67M | |
| End cash position | $495.98M |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $109.45M | $108.39M | $96.05M | $83.52M | $66.57M | +1.0% |
| Operating revenue | $109.45M | $108.39M | $96.05M | $83.52M | $66.57M | +1.0% |
| Cost of revenue | $32.34M | $29.29M | $27.45M | $25.11M | $23.11M | +10.4% |
| Gross profit | $77.11M | $79.10M | $68.60M | $58.42M | $43.47M | -2.5% |
| Research & development | $17.32M | $14.69M | $14.25M | $12.95M | $11.75M | +17.9% |
| Selling, general & admin | $54.29M | $46.57M | $44.02M | $35.83M | $33.34M | +16.6% |
| Total operating expense | $71.60M | $61.26M | $58.27M | $48.78M | $45.09M | +16.9% |
| Operating income | $5.50M | $17.83M | $10.33M | $9.63M | -$1.63M | -69.1% |
| Net interest income | $4.69M | $4.63M | $3.25M | $1.51M | $1.42M | +1.1% |
| Pre-tax income | $7.52M | $18.51M | $6.30M | $5.58M | -$232.00K | -59.4% |
| Tax provision | -$536.00K | $539.00K | $320.00K | -$129.00K | $14.00K | -199.4% |
| Net income | $8.05M | $17.97M | $5.98M | $5.71M | -$246.00K | -55.2% |
| Net income to common | $8.05M | $17.97M | $2.53M | $1.51M | -$246.00K | -55.2% |
| Basic EPS | 0.17 | 0.39 | 0.14 | 0.13 | -0.01 | -56.4% |
| Diluted EPS | 0.15 | 0.34 | 0.11 | 0.13 | -0.01 | -55.9% |
| EBIT | $7.53M | $18.52M | $6.30M | $5.60M | -$200.00K | -59.4% |
| EBITDA | $10.92M | $21.51M | $9.26M | $8.55M | $2.79M | -49.2% |
| Basic shares | 46.40M | 45.93M | 32.19M | 44.72M | 44.72M | +1.0% |
| Diluted shares | 54.46M | 53.03M | 39.39M | 44.72M | 44.72M | +2.7% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $548.63M | $537.45M | $495.98M | $195.15M | — | +2.1% |
| Cash & short-term investments | $548.63M | $537.45M | $495.98M | $195.15M | — | +2.1% |
| Accounts receivable | $74.89M | $61.30M | $41.62M | $34.65M | — | +22.2% |
| Inventory | $21.14M | $19.22M | $17.55M | $17.39M | — | +10.0% |
| Total current assets | $651.38M | $624.14M | $560.56M | $251.72M | — | +4.4% |
| Property, plant & equipment | $72.76M | $71.67M | $66.52M | $66.69M | — | +1.5% |
| Goodwill & intangibles | — | — | $587.00K | — | — | — |
| Total assets | $729.70M | $700.73M | $632.65M | $327.52M | — | +4.1% |
| Total current liabilities | $55.73M | $57.16M | $47.96M | $40.78M | — | -2.5% |
| Long-term debt | $91.03M | $90.00M | $57.23M | $54.99M | — | +1.1% |
| Total debt | $143.92M | $144.19M | $108.89M | $108.14M | — | -0.2% |
| Total liabilities | $192.89M | $195.11M | $152.55M | $567.03M | — | -1.1% |
| Retained earnings | -$248.72M | -$256.78M | -$274.75M | -$280.72M | — | +3.1% |
| Shareholder equity | $536.81M | $505.62M | $480.11M | -$239.51M | — | +6.2% |
| Working capital | $595.65M | $566.98M | $512.60M | $210.93M | — | +5.1% |
| Net tangible assets | $536.81M | $505.62M | $479.52M | -$239.51M | — | +6.2% |
| Shares issued | 46.83M | 45.98M | 45.80M | 44.72M | 44.72M | +1.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $8.05M | $17.97M | $5.98M | $5.71M | -$246.00K | -55.2% |
| Depreciation & amortisation | $3.40M | $2.99M | $2.96M | $2.95M | $2.98M | +13.6% |
| Stock-based compensation | $8.22M | $6.51M | $6.33M | $4.47M | $2.73M | +26.2% |
| Change in working capital | -$11.86M | -$14.52M | -$10.75M | -$7.69M | -$3.10M | +18.3% |
| Operating cash flow | $9.14M | $15.43M | $10.79M | $10.00M | $1.18M | -40.8% |
| Capital expenditure | -$4.05M | -$4.47M | -$1.58M | -$2.12M | -$2.87M | +9.4% |
| Investing cash flow | -$4.05M | -$4.47M | -$1.58M | -$2.12M | -$2.87M | +9.4% |
| Share buybacks | — | — | $0 | $0 | — | — |
| Financing cash flow | $6.09M | $30.52M | $291.61M | -$1.68M | -$949.00K | -80.0% |
| Free cash flow | $5.09M | $10.96M | $9.21M | $7.87M | -$1.69M | -53.6% |
| End cash position | $548.63M | $537.45M | $495.98M | $195.15M | $188.96M | +2.1% |
Options analytics
Put / call volume
2.49
Put-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
65.00
-35.0% from spot
ATM implied vol
0.2%
Nearest strike to spot
Skew (10% OTM)
0.0%
Calls bid over puts
Call volume
180
Contracts, this expiry
Put volume
448
Contracts, this expiry
Heaviest call OI
65.00
0 contracts
Heaviest put OI
70.00
0 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.16 | 0.36 | +124.3% |
| Mar 2026 | -0.01 | — | — |
| Dec 2025 | 0.17 | 0.15 | -10.6% |
| Sep 2025 | 0.16 | 0.91 | +468.8% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.30 | 2 | $115.80M | +38.7% |
| Next quarter | 0.31 | 2 | $121.12M | +26.1% |
| Current year | 1.50 | 2 | $454.78M | +49.1% |
| Next year | 1.49 | 2 | $573.73M | +26.2% |
Analyst targets & ownership
Mean target$129.00
High target$145.00
Low target$110.00
Implied upside29.08%
Analyst count7
ConsensusSTRONG BUY
Strong buy / Buy2 / 5
Hold1
Sell / Strong sell0 / 0
Held by insiders28.35%
Held by institutions45.56%
Institutions holding196
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
112.94
-11.51% from price
SMA 20
108.55
-7.93% from price
SMA 50
106.68
-6.31% from price
SMA 100
107.41
-6.96% from price
SMA 200
95.31
+4.85% from price
EMA 12
108.77
-8.11% from price
EMA 26
107.70
-7.21% from price
EMA 50
107.14
-6.72% from price
RSI (14)
42.6
Neutral
MACD (12,26,9)
1.06
Hist -1.17
ATR (14)
8.24
8.24% of price
Realised vol 30D
68.8%
Annualised
Bollinger upper
124.98
20, 2σ
Bollinger lower
92.12
20, 2σ
50 / 200 cross
Golden
106.68 vs 95.31
Trend bias
Above 200
+4.85%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
1.66
More volatile than market
Correlation to SPY
0.24
Largely independent
Realised vol 30D
68.8%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-50.8%
Peak to trough
Max drawdown 5Y
-50.8%
Peak to trough
ATR 14
8.24
8.24% of price
Beta (reported)
—
5Y monthly, from filing
Short interest
Shares short
2.63M
Prior 1.95M
Change vs prior
+34.7%
Shorts adding
% of float
10.04%
Elevated
% of shares out
5.56%
Against total outstanding
Days to cover
4.7
Liquid
Float
28.82M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Oct 1, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Sep 2, 26 | Canaccord Genuity | INITIATED | — | Buy |
| Aug 6, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| Aug 6, 26 | BTIG | MAINTAINED | Buy | Buy |
| Jun 29, 26 | Guggenheim | INITIATED | Buy | Buy |
| May 13, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| May 7, 26 | JP Morgan | MAINTAINED | Overweight | Overweight |
| May 7, 26 | BTIG | MAINTAINED | Buy | Buy |
| Mar 30, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Mar 5, 26 | Wells Fargo | MAINTAINED | Equal-Weight | Equal-Weight |
| Mar 5, 26 | Guggenheim | MAINTAINED | Buy | Buy |
| Mar 5, 26 | BTIG | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-08-05
Corporate Changes & Voting Matters
8-K · 2026-06-29
Corporate Changes & Voting Matters
8-K · 2026-06-16
Corporate Changes & Voting Matters
8-K · 2026-05-06
Proxy Statements
DEFA14A · 2026-04-21
Periodic Financial Reports
10-K · 2026-03-11
Corporate Changes & Voting Matters
8-K · 2026-03-04
Corporate Changes & Voting Matters
8-K · 2026-01-12
Headlines
BillionToOne (NasdaqGS:BLLN) Stock Fair Value Edges Higher As Analysts Weigh Tech And Reimbursement Risk
Simply Wall St. · 4d ago
BillionToOne Insider Sold Shares Worth $1,326,919, According to a Recent SEC Filing
MT Newswires · 6d ago
Billiontoone Insider Sold Shares Worth $416,625, According to a Recent SEC Filing
MT Newswires · 8d ago
BillionToOne (BLLN) Stock Could Be A Bargain As It Jumps 30% YTD
Simply Wall St. · 14d ago
BillionToOne Stock Jumped 12% Yesterday. Here’s What the Streets Target.
TIKR · 14d ago
BillionToOne SVP Sells 1,416 Shares
Motley Fool · 16d ago
BillionToOne CEO Liquidates Entire Directly-Held Stake in the Company for $3 Million
Motley Fool · 20d ago
BillionToOne Insider Sold Shares Worth $3,030,444, According to a Recent SEC Filing
MT Newswires · 20d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.